Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Transgenic NOD backcross mice expressing pancreatic interleukin 10 (IL-10) were crossed and backcrossed to NOD.B6 Idd3 Idd10 mice, which have diabetes-resistance alleles at Idd3 and Idd10 on chromosome 3 and have a very low frequency diabetes and insulitis. Insulitis and diabetes developed in almost all IL-10 transgenic backcross 1 (BC1) mice of the H2g(7/g7) haplotype regardless of the allelic status at Idd3 and Idd10. Furthermore, diabetes occurred in 23% of IL-10 transgenic H2g(7/d) BC1 mice. These results indicate that pancreatic IL-10 is able to overcome the diabetes protection afforded by C57BL/6 (B6)-derived alleles at Idd3 and Idd10 as well as the absence of NOD MHC homozygosity, if other non-MHC NOD-derived Idd alleles are provided.

Original publication

DOI

10.3109/08916939709008027

Type

Journal article

Journal

Autoimmunity

Publication Date

01/1997

Volume

26

Pages

215 - 221

Addresses

Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Keywords

Pancreas, Animals, Mice, Inbred NOD, Mice, Transgenic, Mice, Diabetes Mellitus, Interleukin-10, Inbreeding, Alleles, Female, Male